For individuals living with Tuberous Sclerosis Complex (TSC), timely, uninterrupted access to therapy is critical but often difficult to navigate. Because TSC is a multisystem condition requiring coordination across neurology, dermatology, nephrology, pulmonology, behavioral health, and primary care, successful treatment depends on collaboration among providers, payers, pharmacies, and caregivers.
When coordination breaks down, delays in starting therapy or interruptions in treatment can occur. These disruptions are especially impactful in neurologic manifestations of TSC, where seizure control is a primary clinical priority and even brief gaps in therapy may affect stability and outcomes.
Specialty pharmacies like Total Care RX help reduce barriers, prevent therapy interruptions, and support patients from prescription through ongoing care.
The Clinical Importance of Treatment Continuity
Neurologic involvement is among the most common and clinically significant aspects of TSC, with more than 80% of individuals developing seizure disorders. Many require long-term therapy beginning in infancy or early childhood, and those with infantile spasms or refractory epilepsy are particularly vulnerable to treatment disruptions.
As treatment options expand with mTOR inhibitors, antiseizure medications, and targeted therapies, care has become more effective but also more administratively complex. Prior authorizations, REMS programs, payer requirements, and monitoring protocols can slow access to therapy.
Emerging data presented at AMCP Nexus 2025 suggest that care fragmentation may increase the likelihood of therapy interruption by approximately 35%. For patients with TSC, these interruptions can contribute to disease instability and increased healthcare utilization.
Where Treatment Delays Commonly Occur
Despite well-established treatment pathways, access barriers in TSC care frequently arise due to:
- Incomplete or inconsistent clinical documentation
- Prior authorization delays or misaligned submissions
- Fragmented communication between prescribers, pharmacies, and payers
- Financial barriers or uncertainty around coverage
- Limited ongoing patient and caregiver support or follow-up after therapy initiation
These challenges often reflect the complexity of the healthcare system rather than clinical intent, making coordinated specialty pharmacy support essential.
How Coordinated Specialty Support Can Reduce Barriers
Access to TSC therapies depends on effective coordination among providers, payers, caregivers, and pharmacy partners. Total Care RX is built to support complex neurological and rare disease therapies and works closely with care teams to streamline access from prescription through ongoing treatment.
Key areas of support include:
End-to-End Access Coordination – From intake through approval, Total Care RX helps ensure clinical documentation is complete, accurate, and aligned with payer requirements to reduce avoidable delays.
Prior Authorization and Appeals Support – Dedicated teams help coordinate submissions, respond to payer inquiries, and assist with appeals to help expedite therapy initiation.
Financial Navigation – Benefits verification, copay assistance screening, and proactive cost discussions help reduce financial-related treatment abandonment or interruption.
Specialty Expertise – Total Care RX brings focused experience supporting complex TSC-associated therapies, including those requiring REMS oversight, frequent dose changes, and enhanced monitoring.
Supporting Patients Beyond Therapy Approval
Access does not end once a medication is approved. For individuals living with TSC, long-term treatment success depends on ongoing education, follow-up, and support.
Total Care RX helps patients and caregivers navigate treatment through:
- Adherence support and caregiver education
- Proactive refill coordination and monitoring
- Ongoing communication with prescribers and care coordinators
- Financial guidance and reassessment of assistance options when needed
This structured approach helps minimize disruptions in therapy, particularly for families managing multiple treatments across different manifestations of TSC.
Supporting Complex Therapies
TSC management often involves therapies that require specialized handling, oversight, and coordination, including:
- Everolimus – an mTOR inhibitor used in multiple manifestations, including SEGA, renal angiomyolipoma, and seizure management
- Vigabatrin – used for infantile spasms and refractory focal seizures
- HYFTOR (sirolimus topical gel 0.2%) – an FDA-approved topical treatment for facial angiofibromas in patients 6 years and older
Total Care RX provides targeted infrastructure and coordination support for these therapies, which frequently involve REMS requirements, prior authorization complexity, and ongoing monitoring.
Reducing Administrative Burden for Care Teams
By serving as a centralized coordination partner, Total Care RX reduces administrative burden through:
- Adherence support
- Benefits verification and financial assistance coordination
- Prior authorization initiation, tracking, and appeals coordination
- Communication between prescribers, caregivers, and payers
This allows care teams to focus more fully on clinical decision-making while helping ensure administrative requirements do not delay treatment.
A Partner in the TSC Care Ecosystem
“TSC requires ongoing coordination across multiple therapies and specialties, particularly in pediatric neurology where patients are often managing complex, evolving treatment regimens,” says Andrew Wroblewski, PharmD, Managing Director of Product and Compliance at Total Care RX. “Our role is to serve as a consistent partner to providers and families, helping ensure that access, communication, and follow-through remain uninterrupted.”
This commitment reflects Total Care RX’s mission to function as a trusted extension of the care team by providing resources and coordination needed to navigate complex treatment pathways.
Strengthening Access Through Collaboration & Access Guide
TSC care requires consistent collaboration among providers, caregivers, payers, and pharmacy partners. Through The Total Care RX Equation™, Total Care RX helps reduce barriers to therapy, streamline access, and support a more seamless care experience for individuals living with TSC.
Download the TSC Access Guide for Neurology & Field Teams to learn more about reducing delays and supporting faster, more reliable access to therapy.
Total Care RX is a sponsor and will be attending the 2026 TSC World Conference. The team looks forward to connecting with the TSC community, learning from leading experts, and engaging in conversations that continue to improve care, access, and outcomes for patients and families impacted by TSC.
Learn more about how Total Care RX supports patients and families living with TSC.